- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ross retires from Imatron
Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a
Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a library.
The position of president was created in 1998 as an enticement for Ross to lead the company. The agreement then was for Ross to stay just two years, long enough to redirect Imatron toward more profitable activities. He remained longer than initially planned. But for the last six weeks Ross has been on vacation. His retirement was not announced until Ross was satisfied that the company was functioning well without him.
CEO S. Lewis Meyer has taken over the helm.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
